Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on Update on Growth Disorders
Recent advancements in the understanding and management of growth disorders have significantly improved outcomes for affected children. Growth disorders, such as growth hormone deficiency (GHD), Turner syndrome, and idiopathic short stature (ISS), often require early diagnosis and intervention for optimal growth and development. The use of recombinant human growth hormone (rhGH) therapy has been a cornerstone in treating many of these conditions, demonstrating substantial benefits in promoting height gain and improving overall health.
Genetic and molecular research has expanded knowledge of the underlying causes of various growth disorders, leading to more precise diagnostic tools and personalized treatment approaches. Innovations in genetic testing can now identify specific mutations responsible for growth impairments, allowing for targeted therapies that address the root causes. Additionally, emerging treatments, such as growth hormone secretagogues and insulin-like growth factor-1 (IGF-1) therapy, offer new avenues for managing growth disorders. Ongoing clinical trials and research continue to refine these therapies, aiming to enhance efficacy and minimize side effects, ultimately improving the quality of life for children with growth disorders.
Therefore, get an overall knowledge of update on growth disorders
See More Webinars @ Hidoc Webinars
1.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
2.
High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?
3.
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic
4.
The pandemic had little impact on mental health symptoms.
5.
How breast tissue density affects your risk of breast cancer
1.
Uncovering Breast Cancer: The Power of Early Stage Ultrasound
2.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
3.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
4.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
5.
Patient-Centric Approaches in Hematology: Integrating Individualized Care into Modern Clinical Practice
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation